| Year |
Citation |
Score |
| 2008 |
Mamedova LK, Wang R, Besada P, Liang BT, Jacobson KA. Attenuation of apoptosis in vitro and ischemia/reperfusion injury in vivo in mouse skeletal muscle by P2Y6 receptor activation. Pharmacological Research : the Official Journal of the Italian Pharmacological Society. 58: 232-9. PMID 18805489 DOI: 10.1016/J.Phrs.2008.08.004 |
0.75 |
|
| 2006 |
Besada P, Mamedova LK, Palaniappan KK, Gao ZG, Joshi BV, Jeong LS, Civan MM, Jacobson KA. NUCLEOSIDE PRODRUGS OF A ADENOSINE RECEPTOR AGONISTS AND ANTAGONISTS. Collection of Czechoslovak Chemical Communications. 71: 912-928. PMID 34815583 DOI: 10.1135/cccc20060912 |
0.764 |
|
| 2006 |
Mamedova LK, Gao ZG, Jacobson KA. Regulation of death and survival in astrocytes by ADP activating P2Y1 and P2Y12 receptors. Biochemical Pharmacology. 72: 1031-41. PMID 16934758 DOI: 10.1016/J.Bcp.2006.07.017 |
0.705 |
|
| 2006 |
Jacobson KA, Costanzi S, Joshi BV, Besada P, Shin DH, Ko H, Ivanov AA, Mamedova L. Agonists and antagonists for P2 receptors. Novartis Foundation Symposium. 276: 58-68; discussion 68. PMID 16805423 DOI: 10.1002/9780470032244.Ch6 |
0.728 |
|
| 2006 |
Gao ZG, Duong HT, Sonina T, Kim SK, Van Rompaey P, Van Calenbergh S, Mamedova L, Kim HO, Kim MJ, Kim AY, Liang BT, Jeong LS, Jacobson KA. Orthogonal activation of the reengineered A3 adenosine receptor (neoceptor) using tailored nucleoside agonists. Journal of Medicinal Chemistry. 49: 2689-702. PMID 16640329 DOI: 10.1021/Jm050968B |
0.778 |
|
| 2006 |
Besada P, Mamedova LK, Palaniappan KK, Gao ZG, Joshi BV, Jeong LS, Civan MM, Jacobson KA. Nucleoside prodrugs of A3 adenosine receptor agonists and antagonists Collection of Czechoslovak Chemical Communications. 71: 912-928. DOI: 10.1135/Cccc20060912 |
0.746 |
|
| 2005 |
Costanzi S, Joshi BV, Maddileti S, Mamedova L, Gonzalez-Moa MJ, Marquez VE, Harden TK, Jacobson KA. Human P2Y(6) receptor: molecular modeling leads to the rational design of a novel agonist based on a unique conformational preference. Journal of Medicinal Chemistry. 48: 8108-11. PMID 16366591 DOI: 10.1021/Jm050911P |
0.775 |
|
| 2005 |
Mamedova L, Capra V, Accomazzo MR, Gao ZG, Ferrario S, Fumagalli M, Abbracchio MP, Rovati GE, Jacobson KA. CysLT1 leukotriene receptor antagonists inhibit the effects of nucleotides acting at P2Y receptors. Biochemical Pharmacology. 71: 115-25. PMID 16280122 DOI: 10.1016/J.Bcp.2005.10.003 |
0.761 |
|
| 2005 |
Kim YC, Lee JS, Sak K, Marteau F, Mamedova L, Boeynaems JM, Jacobson KA. Synthesis of pyridoxal phosphate derivatives with antagonist activity at the P2Y13 receptor. Biochemical Pharmacology. 70: 266-74. PMID 15913566 DOI: 10.1016/J.Bcp.2005.04.021 |
0.797 |
|
| 2005 |
Besada P, Mamedova L, Thomas CJ, Costanzi S, Jacobson KA. Design and synthesis of new bicyclic diketopiperazines as scaffolds for receptor probes of structurally diverse functionality. Organic & Biomolecular Chemistry. 3: 2016-25. PMID 15889186 DOI: 10.1039/B416349D |
0.79 |
|
| 2005 |
Jacobson KA, Mamedova L, Joshi BV, Besada P, Costanzi S. Molecular recognition at adenine nucleotide (P2) receptors in platelets. Seminars in Thrombosis and Hemostasis. 31: 205-16. PMID 15852224 DOI: 10.1055/S-2005-869526 |
0.812 |
|
| 2005 |
Shneyvays V, Leshem D, Zinman T, Mamedova LK, Jacobson KA, Shainberg A. Role of adenosine A1 and A3 receptors in regulation of cardiomyocyte homeostasis after mitochondrial respiratory chain injury. American Journal of Physiology. Heart and Circulatory Physiology. 288: H2792-801. PMID 15681707 DOI: 10.1152/Ajpheart.01157.2004 |
0.478 |
|
| 2004 |
Costanzi S, Mamedova L, Gao ZG, Jacobson KA. Architecture of P2Y nucleotide receptors: structural comparison based on sequence analysis, mutagenesis, and homology modeling. Journal of Medicinal Chemistry. 47: 5393-404. PMID 15481977 DOI: 10.1021/Jm049914C |
0.766 |
|
| 2004 |
Gao ZG, Mamedova LK, Chen P, Jacobson KA. 2-Substituted adenosine derivatives: affinity and efficacy at four subtypes of human adenosine receptors. Biochemical Pharmacology. 68: 1985-93. PMID 15476669 DOI: 10.1016/J.Bcp.2004.06.011 |
0.61 |
|
| 2004 |
Gao ZG, Mamedova L, Tchilibon S, Gross AS, Jacobson KA. 2,2'-Pyridylisatogen tosylate antagonizes P2Y1 receptor signaling without affecting nucleotide binding. Biochemical Pharmacology. 68: 231-7. PMID 15193995 DOI: 10.1016/J.Bcp.2004.02.039 |
0.777 |
|
| 2004 |
Gao ZG, Jeong LS, Moon HR, Kim HO, Choi WJ, Shin DH, Elhalem E, Comin MJ, Melman N, Mamedova L, Gross AS, Rodriguez JB, Jacobson KA. Structural determinants of efficacy at A3 adenosine receptors: modification of the ribose moiety. Biochemical Pharmacology. 67: 893-901. PMID 15104242 DOI: 10.1016/J.Bcp.2003.10.006 |
0.614 |
|
| 2004 |
Mamedova LK, Joshi BV, Gao ZG, von Kügelgen I, Jacobson KA. Diisothiocyanate derivatives as potent, insurmountable antagonists of P2Y6 nucleotide receptors. Biochemical Pharmacology. 67: 1763-70. PMID 15081875 DOI: 10.1016/J.Bcp.2004.01.011 |
0.75 |
|
| 2002 |
Shneyvays V, Mamedova LK, Leshem D, Korkus A, Shainberg A. Insights into the cardioprotective function of adenosine A(1) and A(3) receptors. Experimental and Clinical Cardiology. 7: 138-45. PMID 19649238 |
0.397 |
|
| 2002 |
Shneyvays V, Mamedova LK, Korkus A, Shainberg A. Cardiomyocyte resistance to doxorubicin mediated by A(3) adenosine receptor. Journal of Molecular and Cellular Cardiology. 34: 493-507. PMID 12056854 DOI: 10.1006/jmcc.2002.1532 |
0.501 |
|
| 2002 |
Shainberg A, Leshem D, Mamedova LK, Shneyvays V. Activation of adenosine A1 and A3 receptors protects cardiomyocytes in hypoxia by different mechanisms Journal of Molecular and Cellular Cardiology. 34: A89. DOI: 10.1016/S0022-2828(02)91046-1 |
0.356 |
|
| 2001 |
Shneyvays V, Mamedova L, Zinman T, Jacobson K, Shainberg A. Activation of A(3)adenosine receptor protects against doxorubicin-induced cardiotoxicity. Journal of Molecular and Cellular Cardiology. 33: 1249-61. PMID 11444927 DOI: 10.1006/Jmcc.2001.1387 |
0.636 |
|
| Show low-probability matches. |